Pathogenicity of a human thyroglobulin peptide (2340–2359) in mice with high or low genetic susceptibility to thyroiditis
Aikaterini Hatzioannou(Pasteur Hellenic Institute), Peggy Lymberi(Pasteur Hellenic Institute), Maria Alevizaki(National and Kapodistrian University of Athens), Evangelos Karras(Pasteur Hellenic Institute), Apollon Thrasyvoulides(Pasteur Hellenic Institute), Elisavet Liakata(Pasteur Hellenic Institute)
Cited by 5
Related Papers
Studies of insulin resistance in patients with clinical and subclinical hypothyroidism
|European Journal of Endocrinology|2009|459
Renal dysfunction in acute stroke: an independent predictor of long-term all combined vascular events and overall mortality
|Nephrology Dialysis Transplantation|2008|191
Impaired Endothelium-Dependent Vasodilatation in Women With Previous Gestational Diabetes
|Diabetes Care|1998|189
High serum cholesterol levels in persons with 'high-normal' TSH levels: should one extend the definition of subclinical hypothyroidism?
|European Journal of Endocrinology|1998|164
The Role of Diet and Lifestyle in Primary, Secondary, and Tertiary Diabetes Prevention: A Review of Meta-Analyses
|The Review of Diabetic Studies|2010|131